Clinical trial SYD1875.001
A first-in-human dose-escalation and expansion study with the antibody-drug conjugate SYD1875 to evaluate the safety, pharmacokinetics and efficacy in patients with 5T4-expressing locally advanced or metastatic solid tumours (SYD1875.001)
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Byondis |
| EudraCT Identifier | 2019-002916-13 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04202705 |
| Inclusion criteria | 5T4 positive tumors (IHC++/+++) |
| Last update |